237 related articles for article (PubMed ID: 32647264)
41. GNAS gene mutations affecting XLαs and bone health: A long neglected relationship.
Xie Y; Chen X; Xie Y; Yu X
Clin Genet; 2023 Sep; 104(3):279-286. PubMed ID: 37249323
[TBL] [Abstract][Full Text] [Related]
42. A maternal epimutation of GNAS leads to Albright osteodystrophy and parathyroid hormone resistance.
Mariot V; Maupetit-Méhouas S; Sinding C; Kottler ML; Linglart A
J Clin Endocrinol Metab; 2008 Mar; 93(3):661-5. PubMed ID: 18182455
[TBL] [Abstract][Full Text] [Related]
43. Autosomal-dominant pseudohypoparathyroidism type Ib is caused by different microdeletions within or upstream of the GNAS locus.
Jüppner H; Linglart A; Fröhlich LF; Bastepe M
Ann N Y Acad Sci; 2006 Apr; 1068():250-5. PubMed ID: 16831926
[TBL] [Abstract][Full Text] [Related]
44. A novel mutation in a case of pseudohypoparathyroidism type Ia.
Kırel B; Demiral M; Bozdağ Ö; Karaer K
Turk J Pediatr; 2016; 58(1):101-105. PubMed ID: 27922245
[TBL] [Abstract][Full Text] [Related]
45. Genetic analysis and evaluation of resistance to thyrotropin and growth hormone-releasing hormone in pseudohypoparathyroidism type Ib.
Mantovani G; Bondioni S; Linglart A; Maghnie M; Cisternino M; Corbetta S; Lania AG; Beck-Peccoz P; Spada A
J Clin Endocrinol Metab; 2007 Sep; 92(9):3738-42. PubMed ID: 17595244
[TBL] [Abstract][Full Text] [Related]
46. Progressive osseous heteroplasia, as an isolated entity or overlapping with Albright hereditary osteodystrophy.
Lin MH; Numbenjapon N; Germain-Lee EL; Pitukcheewanont P
J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):911-8. PubMed ID: 25894639
[TBL] [Abstract][Full Text] [Related]
47. Current Nomenclature of Pseudohypoparathyroidism: Inactivating Parathyroid Hormone/Parathyroid Hormone-Related Protein Signaling Disorder.
Turan S
J Clin Res Pediatr Endocrinol; 2017 Dec; 9(Suppl 2):58-68. PubMed ID: 29280743
[TBL] [Abstract][Full Text] [Related]
48. Different AHO phenotype in a Chinese family with a novel GNAS missense variant: a case report.
Zhou Q; Liang B; Fu QX; Liu H; Zou CC
Ital J Pediatr; 2022 Jul; 48(1):123. PubMed ID: 35871092
[TBL] [Abstract][Full Text] [Related]
49. Evidence of hormone resistance in a pseudo-pseudohypoparathyroidism patient with a novel paternal mutation in GNAS.
Turan S; Thiele S; Tafaj O; Brix B; Atay Z; Abali S; Haliloglu B; Bereket A; Bastepe M
Bone; 2015 Feb; 71():53-7. PubMed ID: 25464124
[TBL] [Abstract][Full Text] [Related]
50. Recent advances in GNAS epigenetic research of pseudohypoparathyroidism.
Izzi B; Van Geet C; Freson K
Curr Mol Med; 2012 Jun; 12(5):566-73. PubMed ID: 22300135
[TBL] [Abstract][Full Text] [Related]
51. Genetic and epigenetic defects at the GNAS locus cause different forms of pseudohypoparathyroidism.
Jüppner H
Ann Endocrinol (Paris); 2015 May; 76(2):92-7. PubMed ID: 25882888
[No Abstract] [Full Text] [Related]
52. Phenotypic and molecular genetic aspects of pseudohypoparathyroidism type Ib in a Greek kindred: evidence for enhanced uric acid excretion due to parathyroid hormone resistance.
Laspa E; Bastepe M; Jüppner H; Tsatsoulis A
J Clin Endocrinol Metab; 2004 Dec; 89(12):5942-7. PubMed ID: 15579741
[TBL] [Abstract][Full Text] [Related]
53. Clinical review: Pseudohypoparathyroidism: diagnosis and treatment.
Mantovani G
J Clin Endocrinol Metab; 2011 Oct; 96(10):3020-30. PubMed ID: 21816789
[TBL] [Abstract][Full Text] [Related]
54. Identification of a novel GNAS mutation in a family with pseudohypoparathyroidism type 1A.
Sippelli F; Briuglia S; Ferraloro C; Capra AP; Agolini E; Abbate T; Pepe G; Aversa T; Wasniewska M; Corica D
BMC Pediatr; 2024 Apr; 24(1):271. PubMed ID: 38664677
[TBL] [Abstract][Full Text] [Related]
55. Genetics and epigenetics of parathyroid hormone resistance.
Bastepe M
Endocr Dev; 2013; 24():11-24. PubMed ID: 23392091
[TBL] [Abstract][Full Text] [Related]
56. A pseudohypoparathyroidism type Ia patient with normocalcemia.
Tamada Y; Kanda S; Suzuki H; Tajima T; Nishiyama T
Endocr J; 2008 Mar; 55(1):169-73. PubMed ID: 18250541
[TBL] [Abstract][Full Text] [Related]
57. Sporadic pseudohypoparathyroidism type-1b with asymptomatic hypocalcemia.
Goto M; Yamamoto Y; Ishii M; Nakamura A; Sano S; Kagami M; Fukami M; Saito R; Araki S; Kubo K; Kawagoe R; Kawada Y; Kusuhara K
Pediatr Int; 2016 Nov; 58(11):1229-1231. PubMed ID: 27882740
[TBL] [Abstract][Full Text] [Related]
58. A novel GNAS variant presents with disorders of GNAS inactivation and cardiomyopathy.
Shelkowitz E; Chan CM; Jones T; Nakano SJ; Meeks NJL
Am J Med Genet A; 2022 Jul; 188(7):2147-2152. PubMed ID: 35347857
[TBL] [Abstract][Full Text] [Related]
59. Two mutations of the Gsalpha gene in two Japanese patients with sporadic pseudohypoparathyroidism type Ia.
Ishikawa Y; Tajima T; Nakae J; Nagashima T; Satoh K; Okuhara K; Fujieda K
J Hum Genet; 2001; 46(7):426-30. PubMed ID: 11450852
[TBL] [Abstract][Full Text] [Related]
60. Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues.
Mantovani G; Spada A; Elli FM
Nat Rev Endocrinol; 2016 Jun; 12(6):347-56. PubMed ID: 27109785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
